 |
PET/CT scanners provide complimentary diagnostic images to provide a complete diagnostic evaluation.
PET uses radioactive glucose, fluordeoxyglucose (FDG), to detect areas of altered cellular function. This information can be used in the management of neurologic and cardiovascular disorders as well as cancer.
CT imaging uses radiation to precisely define a patient’s anatomy.
Together PET/CT imaging provides functional and anatomic information.
|
 |
 |
 Head and Neck cancer
Thyroid cancer
Pulmonary nodule
Lung Cancer
Breast Cancer
Cervical
Ovarian Cancer
Esophageal cancer
Lymphoma
Prostate
|
Colorectal
Hodgkins Disease
Non-Hodgkins Disease
Sarcoma
Melanoma
Cardiovascular
Epilepsy, Brain Tumor and Alzheimer’s
Refractory Seizures |
|
|
|
|
|
 |
|
|
